Alterations of coagulation and fibrinolysis in patients with blunt splenic injury after splenic artery embolization

Chuanzeng Ren,Huadong Lu,Honghai Xia,Jia Zhang,Bin Cao,Ying Wang,Dong Lu,Rongge Cao
DOI: https://doi.org/10.1002/jcla.23801
IF: 3.124
2021-05-06
Journal of Clinical Laboratory Analysis
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Thrombotic complications following splenectomy have been documented. However, there has been sparse literature regarding thrombotic complications following splenic artery embolization (SAE).The objective of this study was to determine changes in coagulation and fibrinolysis and assess the thrombotic risk after SAE in patients with blunt splenic injury (BSI).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>This study included 38 BSI patients who were hemodynamically stable on admission. SAE was performed if the splenic injury was classed as grade III or greater and had no requirement of immediate surgery. Platelet (PLT), fibrinogen (FIB), D‐dimers (D‐D), fibrinogen/fibrin degradation products (FDP), antithrombin III (AT III), prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), hemoglobin (Hb), and hematocrit (Hct) were measured before SAE procedures and then 1d, 3d, and 7d after SAE.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The technical success rate of SAE and the splenic salvage rate were 100%. There was no mortality. Compared with pre‐SAE values, the levels of PLT, FIB, D‐D, and FDP increased significantly at 3 days and 7 days after SAE (<i>p</i> &lt; 0.05). However, AT III, PT, APTT, TT, Hb, and Hct showed no statistically significant difference at 1d, 3d, and 7d after SAE (<i>p</i> &gt; 0.05). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Alterations in PLT and hemostatic parameters might contribute to the increased risk of thrombotic complications in BSI patients undergoing SAE. Thromboembolism following SAE should be considered and thrombotic prophylaxis should be recommended.</p></section>
medical laboratory technology
What problem does this paper attempt to address?